06-08-2017, 04:27 PM
1) Background:
1.1) Overview
1.1) Overview
Quote:
Name:
Jason KellyAffiliation
Liberty/ZonerEmployment:
Cryer Pharmaceuticals - Chief Operating Officer (COO)Other related Businesses:
Kelly Import & Export LLC (full ownership)
Kelly Stock Exchange LLC (full ownership)
Omicron Supply Industries (former CEO)
Interspace Commerce (former Chairman of the Board of Directors (non-executive))
The Sol Project (pending negotiation)
1.2) Biography
Born on the 9th March 759 A. S. on Planet Los Angeles as son of a sales manager of the local Synth Foods company. Upon graduating from the Marshall School of Business he started his own small transport business with the financial support of his father.
After expanding from domestic market of Liberty to the import-export business one of his employees got in touch with Omicron Supply Industries.
Realizing that as independent contractor of OSI he could reach into markets he had never imagined to see, he signed a contract with OSI that allowed him to fly under Zoner colors without actually giving up his own company.
The success of this cooperation soon caught the eyes of others and as his personal wealth grew so did his reputation within OSI. His ruthlessness in conquering new markets and exploitation of market opportunities made him both feared as competitor and respected as colleague among his peers.
He relocated the headquarter of his contract-business to an office within the OSI-headquarter on Planet Gran Canaria, where he felt more as an integral part of OSI than a mere subcontractor.
However, his rise within the ranks of OSI only began as Kelly on numerous occasions overstepped his competence and made deal on behalf of OSI, while fulfilling them with his contractual company.
In the end he was found out and had to explain himself in front of the directors. Due to the fact that all of his customers were full of praise – which he skillfully emphasized – and the support of the then-directors Caudill and Church he was promoted to Adviser of the board and continued to sign contracts on behalf of OSI legally.
With the retirement of both Caudill and Church new director position became available and with the new CEO VonCloud he began to take OSI into new directions, that included his aggressive approach to new markets.
After VonCloud stepped down, Kelly was nominated CEO and continued the success story that was Omicron Supply Industries. However, as time progressed, the position of CEO became more and more the position of the head of a political entity. Kelly was well out of his comfort zone as business negotiation became political statements. Not being or wanting to be a political figure he retired from the position as OSI’s CEO and went back to liberty.
However, his retirement was cut short as he was approached to restructure the slowly fading Interspace Commerce. Seeing an opportunity to be a pure businessman again, he took on the challenge. After bringing Interspace Commerce back on the road to success, Kelly settled for the position of Chairman
The position of a non-executive Chairman of the board of directors gave Kelly both ample influence on the company as well as representing his favorite kind of people on the board of directors: The shareholders.
Not being an active part in the day-to-day business of Interspace Commerce shielded Kelly from much of the stress of management positions and provides him with some spare time. So it was not uncommon to see him mentoring on the liberty chamber of commerce, writing the odd article about best practices in the world of business or following his hobbies.
But as time went on the Board of Interspace Commerce grew complacent and listened less and less to the advice of their most senior Member, he left IC, to focus on growing his own business.
However, another Libertonian company did not agree with Kellys plans and recruited him back into the corporate world: Cryer Pharmaceuticals and the all around carefree healthcare offered by Cryer to convince him to stay, was too good an offer to reject for Kelly, who has started to feel the effect of age.